We are delighted to add a summary of a recent seminar event titled; Introduction to Ofatumumab for treatment of relapsing forms of Multiple Sclerosis.
The presentation was given by Professor Heinz Wiendl (University of Münster, Germany), who discussed the landscape related to B cell-depleting therapies and key clinical data relevant to Ofatumumab, and Professor Jeannette Lechner-Scott (University of Newcastle, Newcastle), who discussed B cell therapy and real-world experience with Ofatumumab.
Please login below to download this issue (PDF)